Xanthigen supplement for weight and metabolic health in overweight adults
Tests the Xanthigen supplement in overweight or obese adults over 16 weeks.
Plain-language title generated from the registry record
Registry title: Xanthigen and Its Impact on Weight and Metabolic Health
Key facts
- Where
- Murcia, SpainSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 20 and 50 years old?
Source: NCT07519980, who can take part
Where in Spain
- UCAM HiTech, Sport & Health Innovation HubMurcia, SpainTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Universidad Católica San Antonio de Murcia
- Trial code
- NCT07519980
- Record updated
- 7 May 2026
- Original description
Randomized, controlled, triple-blind clinical trial with three parallel arms based on the product consumed (low-dose experimental product, high-dose experimental product, and placebo product) and conducted at a single center to measure the efficacy of a product (Xanthigen®) on overweight or obesity during 16 weeks of consumption.Read full original descriptionShow less
Effects of Xanthigen on Weight Control and Metabolic Variables in Overweight Individuals
Randomized, controlled, triple-blind clinical trial with three parallel arms based on the product consumed (low-dose experimental product, high-dose experimental product, and placebo product) and conducted at a single center to measure the efficacy of a product (Xanthigen®) on overweight or obesity during 16 weeks of consumption.
Inclusion: The subject is able and willing to follow the study protocol procedures to sign the informed consent form prior to the evaluations; Participants must be between 20 and 50 years of age at the time of consent; The subject is in good physical and mental health as determined by medical history, physical examination, electrocardiogram, vital signs, biochemistry, and hematology results; Participants must have a BMI between 27 and 29.9 kg/cm2; Desire to lose weight.
Exclusion: Relevant medical history or presence of any medical condition that could interfere with this study, such as a previous diagnosis of diabetes, hypertension, hyperlipidemia, cardiovascular disease, thyroid disease, asthma, arthritis, or inflammatory conditions; Chronic intake of medications/dietary supplements with an impact on body weight or body composition or lipid-modifying products (e.g., protein shakes, statins, omega-3 fatty acids, etc.) 2 months prior to selection or during the study; Known allergy/sensitivity to any of the components of the investigational product; Change in hormonal contraception or any use of hormone replacement therapy (HRT) during or at least 3 months prior to the study (if female); History and/or presence of eating disorders such as bulimia, anorexia nervosa, or binge eating, as determined by the investigator; History and/or presence of eating disorders such as bulimia, anorexia nervosa, binge eating, as determined by the investigator; Gastrointestinal diseases/conditions (colitis ulcers, Crohn's disease, peptic ulcers, celiac disease); Fasting blood sugar levels greater than 125 mg/dL and/or total cholesterol levels greater than or equal to 240 mg/dL; Women of childbearing age who are pregnant or intend to become pregnant during the study period; Blood pressure levels below 90/140 mm Hg (diastolic/systolic); Use of any dietary supplements (except mineral supplements, e.g., Ca, Mg); Participation in any weight loss intervention or recent change in body weight > 4.5 kg during the last 9 months; Consumption of any dietary supplements (except mineral supplements, e.g., Ca, Mg); Participation in any weight loss program or recent change in body weight > 4.5 kg during the last 9 months; Individuals who currently participate in aerobic exercise more than 4 times per week, or more than 2.5 hours per week; Vegan lifestyle; Current smoker or user of nicotine products or cessation of smoking within 1 year of the screening date.